SEC Form 4 · accession 0001628280-19-000436
HARTE HANKS INC · HHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy E. Breen
Officer — CEO · Director
Period of report
Jan 17, 2019
Accepted (ET)
Jan 22, 2019 · 8:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000045919
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 17, 2019 | A | 236,594 | A | — | — | Common Stock | 236,594 | 236,594 | D |
Explanation of responses
- F1The grant of restricted stock units is in the amount of $750,000, which amount was calculated by dividing $750,000 by the Issuer's closing share price on the date of grant of $3.17.
- F2Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. These restricted stock units were issued pursuant to the Harte-Hanks, Inc. 2013 Omnibus Incentive Plan and the corresponding Restricted Stock Unit Award Agreement, and vest if, following a period of at least one full year from the date of grant, the closing price of a share of the Issuer's common stock for 30 consecutive days following the grant date reaches (i) $6.00 per share for the first one-third of the restricted stock units, (ii) $10.00 per share for the second one-third of the restricted stock units and (iii) $12.50 per share for the final one-third of the restricted stock units.